http://orcid.org/0000-0001-9754-356X
References
- Brasil. (2004). Recomendações para Terapia Anti-Retroviral em Adultos e Adolescentes Infectados pelo HIV. Brasília: Ministério da Saúde.
- Brasil, Ministério da Saúde, Secretaria de Vigilância em Saúde, & Departamento de DST, Aids e Hepatites Virais. (2006). Boletim Epidemiológico AIDS e DST. Brasília: Ministério da Saúde.
- Cardoso, S. W., Luz, P. M., Velasque, L., Torres, T. S., Tavares, I. C., Ribeiro, S. R., & Grinsztejn, B. (2014). Outcomes of second-line combination antiretroviral therapy for HIV-infected patients: A cohort study from Rio de Janeiro, Brazil. BMC Infectious Diseases, 14, 1–11. doi: 10.1186/s12879-014-0699-5
- Menezes de Pádua, C. A., & Moura, C. S. (2014). Availability of data on adverse reactions to antiretroviral drugs in medical charts according to the Naranjo algorithm: An example of a Brazilian historical cohort. Clinical Drug Investigation, 34(6), 395–402. doi:10.1007/s40261-014-0187-0 doi: 10.1007/s40261-014-0187-0
- Mocroft, A., Vella, S., Benfield, T. L., Chiesi, A., Miller, V., Gargalianos, P., … Lundgren, J. D. (1998). Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group. The Lancet, 352, 1725–1730. England. doi: 10.1016/S0140-6736(98)03201-2
- Pineirua, A., Sierra-Madero, J., Cahn, P., Guevara Palmero, R. N., Martinez Buitrago, E., Young, B., & Del Rio, C. (2015). The HIV care continuum in Latin America: Challenges and opportunities. The Lancet Infectious Diseases, 15(7), 833–839. doi:10.1016/s1473-3099(15)00108-5 doi: 10.1016/S1473-3099(15)00108-5
- Tsuchiya, N., Pathipvanich, P., Wichukchinda, N., Rojanawiwat, A., Auwanit, W., Ariyoshi, K., & Sawanpanyalert, P. (2014). Incidence and predictors of regimen-modification from first-line antiretroviral therapy in Thailand: A cohort study. BMC Infectious Diseases, 14, 27–35. doi: 10.1186/s12879-014-0565-5
- Wolff, M., Shepherd, B. E., Cortes, C., Rebeiro, P., Cesar, C., Wagner Cardoso, S., … McGowan, C. C. (2016). Clinical and virologic outcomes after changes in first antiretroviral regimen at 7 sites in the Caribbean, Central and South America Network. JAIDS Journal of Acquired Immune Deficiency Syndromes, 71(1), 102–110. doi:10.1097/qai.0000000000000817 doi: 10.1097/QAI.0000000000000817